Intelligent Medicine Acqu...

NASDAQ: IQMD · Real-Time Price · USD
11.04
0.79 (7.71%)
At close: Sep 17, 2024, 10:00 PM

Intelligent Medicine Acquisition Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a
Cost of Revenue
n/a n/a
Gross Profit
n/a n/a
Operating Income
n/a n/a
Interest Income
n/a n/a
Pretax Income
11.97M n/a
Net Income
11.41M n/a
Selling & General & Admin
1.28M n/a
Research & Development
n/a n/a
Other Expenses
n/a n/a
Operating Expenses
1.28M n/a
Interest Expense
n/a n/a
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
1.28M n/a
Income Tax Expense
562.57K n/a
Shares Outstanding (Basic)
23.29M 25.88M
Shares Outstanding (Diluted)
23.29M 25.88M
EPS (Basic)
0.49 n/a
EPS (Diluted)
0.49 n/a
EBITDA
-14.54M n/a
EBIT
-14.54M n/a
Depreciation & Amortization
n/a 236.56K